Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population

BACKGROUND: Insulin Degludec (IDeg) is a new ultra-long-acting basal insulin that has not been yet evaluated in Indian pediatric population. We aim to evaluate the efficacy and safety of IDeg as basal-bolus therapy in Indian pediatric patients affected by type 1 diabetes mellitus (T1DM). METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Kochar, Inderpal Singh, Sethi, Aashish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064114/
https://www.ncbi.nlm.nih.gov/pubmed/30069184
http://dx.doi.org/10.1186/s13633-018-0059-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064114/
https://www.ncbi.nlm.nih.gov/pubmed/30069184
http://dx.doi.org/10.1186/s13633-018-0059-0

Ejemplares similares